With the 2021 update to the WHO classification of tumours of the central nervous system, the use of molecular data, namely IDH mutation and whole arm codeletion of chromosomes 1p and 19q, now supersedes classical histology based classification of LGG [1]. The gene discussed is IDH2; the disease is central nervous system cancer.